Appeal No. 2005-1164 Page 2
Application No. 09/721,131
month, (ii) less than a toxic amount measured by TCLo, the
dosage for oral consumption that is the lowest dosage of
sodium chloride that has produced toxic side effects in humans,
and (iii) less than a toxic amount measured by LD50, the
dosage of sodium chloride that is lethal for 50% of the human
population;
(b) periodically repeating (a), so as to administer a therapeutically
effective amount of the sodium chloride formulation to the
human’s metabolism; and
(c) achieving alleviation of the HIV infection.
27. The method of claim 22, wherein the sodium chloride formulation is a
mixture with a form of potassium in a weight ratio amount of Na:K up
to about 1:1.
28. The method of claim 27, wherein the mixture contains up to about
20% by weight of another ingredient selected from the group
consisting of S, P, Zn, Mn, Fe, Cu, Cr, I, Mg, Co, Se, and
combinations thereof.
The references relied upon by the examiner:
Hrinda et al. (Hrinda) 5,661,023 August 26, 1987
MARTINDALE The Extra Pharmacopoeia, pp. 851-863, 1033, 1034 (James E.F.
Reynolds ed. 13th ed., The Pharmaceutical Press 1993)
Zabel, “Salt water soaking possible alternative psoriasis treatment now available
in Germany,” Dermatology Times, pp. S20 (1996), STN/CAS online transcript,
Acc. No. 96:637898
(Goldman), Cecil Textbook of Medicine, pp. 1889, 1904-1907, and 1933-1945
(Lee Goldman et al., eds., 21st ed. Volume 2, W.B. Saunders Co., 2000)
Drug Facts and Comparisons, pp. 46, and 116-117 (54th ed., Facts and
Comparisons® a Wolters Kluwer Co., 2000)
GROUNDS OF REJECTION
Claims 22-42 stand rejected under 35 U.S.C. § 101 and § 112, first
paragraph, as lacking utility.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: November 3, 2007